Stem Cells and Human Development
Stem cells have tremendous potential for treating disease and replacing or regenerating the diseased tissue. Stem cells have enormous potential in health and medical research but to fully harness this potential, scientists are studying how stem cells transform, or differentiate, into the diverse range of specialized cells that make humans what they are today.
 

The potential benefit of stem cell therapy for spinal cord injuries is remarkable in that it may one day reverse what is currently an irreversible condition.
Arthritis
Rheumatoid Arthritis, through the use of stem cells, these procedures helps patients who don’t respond to typical drug treatment.
 

These non-surgical stem cell injection procedures happen within a single day and may offer a viable alternative for those who are facing surgery or even joint replacement. Patients are typically able to return to normal activity following the procedure and are able to avoid the painful and lengthy rehabilitation periods that are typically required to help restore strength, mobility and range-of-motion following invasive joint surgeries. Lastly, patients are far less vulnerable to the risks of surgeries, such as infection and blood clots.

Burn victims
Cardiovascular diseases

• Adherence to GMP regulations as required by the DCGI/FDCA
• Precisely followed Standard Operating Procedure
• Strict Quality Control (QC) and Quality Assurance (QA), with each being done by different individuals
• Testing of final products according to FDA guidance and requirements
• Rigorous personnel training and proficiency testing
• Meticulous documentation and record keeping
• Readiness for audits

• We are the pioneer Indian pharmaceutical company involved in the stem cell research
• The manufacture of quality products for clinical application
• Pass-through results by adopting GMP protocols and regulatory norms of products as expected by Experts and national auditors of DCGI/FDA in the facility audit meeting.

The company is involved with the creation of significant biotechnology research capabilities in the area of targeted human therapeutic proteins. The Current status of the project has reached preclinical evaluation. Knowing the superiority of the technology and export market Century has decided to conduct the preclinical activity in aboard on transgenic animals.
This plat form technology has been successfully demonstrated at clinical level make the pavement to develop biomolecules for signal and receptor mediated diseases using this technology like cancer. Human phase-1 clinical trial is expected in 2017.
We are the first SME organization to start this new business model of a “Research Boutique”.

Fusion protein
Mast cell
Asthma and allergy
Pledged to develop drug candida